Updated on 4 June 2012
The revenue of Sinopharm Group stood at $16.4 billion in 2011
Sinopharm Group continued to dominate the pharmaceutical industry in China and across the Asia Pacific region in 2011. With China's 12th Five Year Plan for pharmaceutical distribution industry taking off in 2011, Sinopharm molded its business strategy to the tune of country's changing policy. China is formulating policies to promote and facilitate continued rapid development of pharmaceutical industry. Seizing the opportunity, Sinopharm expanded its extensive distribution network to 46 distribution centers through acquisitions and new establishments.
Sinopharm Group recorded the highest growth rate of 60 percent in 2011. The total sales revenue increased from $10.23 billion in 2010 to $16.4 billion in 2011. Sinopharm has already secured a leading position in tier I cities and, in 2011, the group expanded its business in tier II and III cities to reach out to 174 cities. The group is now covering 72.32 percent of all the hospitals in China and is further expanding its pharmaceutical distribution network.